electroCore (ECOR) Competitors $6.02 +0.04 (+0.67%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$6.08 +0.06 (+1.00%) As of 04/17/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ECOR vs. LNSR, BWAY, CATX, LAKE, PROF, ZJYL, SKIN, SGHT, KRMD, and LUCDShould you be buying electroCore stock or one of its competitors? The main competitors of electroCore include LENSAR (LNSR), BrainsWay (BWAY), Perspective Therapeutics (CATX), Lakeland Industries (LAKE), Profound Medical (PROF), Jin Medical International (ZJYL), Beauty Health (SKIN), Sight Sciences (SGHT), KORU Medical Systems (KRMD), and Lucid Diagnostics (LUCD). These companies are all part of the "medical equipment" industry. electroCore vs. LENSAR BrainsWay Perspective Therapeutics Lakeland Industries Profound Medical Jin Medical International Beauty Health Sight Sciences KORU Medical Systems Lucid Diagnostics LENSAR (NASDAQ:LNSR) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability. Does the MarketBeat Community believe in LNSR or ECOR? electroCore received 161 more outperform votes than LENSAR when rated by MarketBeat users. Likewise, 62.55% of users gave electroCore an outperform vote while only 37.50% of users gave LENSAR an outperform vote. CompanyUnderperformOutperformLENSAROutperform Votes637.50% Underperform Votes1062.50% electroCoreOutperform Votes16762.55% Underperform Votes10037.45% Do analysts rate LNSR or ECOR? LENSAR currently has a consensus target price of $15.00, suggesting a potential upside of 7.84%. electroCore has a consensus target price of $25.50, suggesting a potential upside of 323.59%. Given electroCore's stronger consensus rating and higher possible upside, analysts plainly believe electroCore is more favorable than LENSAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, LNSR or ECOR? LENSAR has higher revenue and earnings than electroCore. LENSAR is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLENSAR$53.49M3.07-$14.38M-$2.72-5.11electroCore$25.18M1.72-$18.83M-$1.62-3.72 Is LNSR or ECOR more profitable? LENSAR has a net margin of -34.03% compared to electroCore's net margin of -54.40%. LENSAR's return on equity of -49.02% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets LENSAR-34.03% -49.02% -21.12% electroCore -54.40%-154.45%-69.16% Which has more volatility & risk, LNSR or ECOR? LENSAR has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Do institutionals & insiders have more ownership in LNSR or ECOR? 40.2% of LENSAR shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 38.5% of LENSAR shares are owned by company insiders. Comparatively, 19.7% of electroCore shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer LNSR or ECOR? In the previous week, electroCore had 3 more articles in the media than LENSAR. MarketBeat recorded 4 mentions for electroCore and 1 mentions for LENSAR. LENSAR's average media sentiment score of 1.00 beat electroCore's score of 0.48 indicating that LENSAR is being referred to more favorably in the media. Company Overall Sentiment LENSAR Positive electroCore Neutral SummaryLENSAR and electroCore tied by winning 9 of the 18 factors compared between the two stocks. Get electroCore News Delivered to You Automatically Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ECOR vs. The Competition Export to ExcelMetricelectroCoreElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.30M$3.10B$5.30B$7.34BDividend YieldN/A1.79%5.12%4.30%P/E Ratio-3.2914.8721.8617.80Price / Sales1.7243.57380.5497.74Price / CashN/A44.0938.2634.64Price / Book4.853.336.453.98Net Income-$18.83M$94.03M$3.22B$247.81M7 Day Performance8.08%0.09%2.85%1.80%1 Month Performance-28.16%-7.98%-8.67%-6.81%1 Year Performance6.74%-20.04%11.46%1.31% electroCore Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ECORelectroCore3.211 of 5 stars$6.02+0.7%$25.50+323.6%+6.7%$43.30M$25.18M-3.2950News CoverageGap DownLNSRLENSAR0.9722 of 5 stars$13.68+1.4%$15.00+9.6%+343.0%$161.27M$53.49M-9.37110Short Interest ↓BWAYBrainsWay3.6416 of 5 stars$8.32-1.7%$13.17+58.3%+72.0%$156.99M$41.02M83.21120Short Interest ↓Positive NewsGap DownCATXPerspective Therapeutics3.1892 of 5 stars$2.05+5.1%$12.75+522.0%N/A$151.81M$1.43M0.0070Gap UpLAKELakeland Industries4.8795 of 5 stars$15.95-0.5%$28.25+77.1%-5.1%$151.51M$151.82M-177.221,800Analyst ForecastPROFProfound Medical1.9942 of 5 stars$4.76+1.5%$14.25+199.4%-39.0%$142.99M$10.68M-3.55150Gap UpZJYLJin Medical InternationalN/A$0.87+18.7%N/A-76.4%$135.87M$23.50M0.00245News CoveragePositive NewsGap UpSKINBeauty Health1.7522 of 5 stars$1.00-4.8%$2.50+150.0%-75.3%$125.25M$334.29M-2.381,030Gap UpSGHTSight Sciences3.2936 of 5 stars$2.41+1.3%$3.83+59.1%-49.2%$123.71M$79.87M-2.36210Gap UpKRMDKORU Medical Systems2.874 of 5 stars$2.46+7.0%$4.70+91.1%+10.2%$113.05M$33.65M-9.8480LUCDLucid Diagnostics2.2221 of 5 stars$1.19+1.7%$3.40+185.7%+51.3%$108.00M$4.35M-1.0470High Trading Volume Related Companies and Tools Related Companies LNSR Competitors BWAY Competitors CATX Competitors LAKE Competitors PROF Competitors ZJYL Competitors SKIN Competitors SGHT Competitors KRMD Competitors LUCD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ECOR) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding electroCore, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share electroCore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.